HedgePath Pharmaceuticals, Inc. Contracts & Agreements
85 Contracts & Agreements
- Business Finance (46 contracts)
- Business Formation (1)
- Business Operations (3)
- Human Resources (9)
- Intellectual Property (5)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (19)
- Consulting Agreement by and among Inhibitor Therapeutics, Inc., and Dr. Elizabeth Billingsley (Filed With SEC on October 18, 2023)
- Employment Agreement by and between the Company and James A. McNulty, dated December 13, 2022 (Filed With SEC on December 19, 2022)
- Stipulation and Agreement of Compromise, Settlement, and Release, dated September 9, 2022 (Filed With SEC on December 19, 2022)
- License Agreement by and between the Company and Mayne, dated December 13, 2022 (Filed With SEC on December 19, 2022)
- Employment Agreement by and between the Company and Francis E. ODonnell, dated December 13, 2022 (Filed With SEC on December 19, 2022)
- Letter Agreement to Amend Term Debt Facility, dated March 9, 2022, between the Company and Mayne Pharma (Filed With SEC on March 30, 2022)
- Letter Agreement to Amend Term Debt Facility, dated January 13, 2022, between the Company and Mayne Pharma (Filed With SEC on January 18, 2022)
- Letter Agreement for Term Debt Facility, dated December 12, 2020, between the Company and Mayne Pharma (Filed With SEC on December 17, 2020)
- Promissory Note, dated May 2, 2020, by and between the Company and Citibank, N.A (Filed With SEC on May 6, 2020)
- Sublicense Agreement, dated August 27, 2019, by and between Mayne Pharma International Pty Ltd and the Company (Certain information has been redacted in the marked portions of the... (Filed With SEC on November 7, 2019)
- Agreement, dated December 17, 2018, by and among Mayne Pharma, Mayne Pharma International and the Company (Filed With SEC on March 7, 2019)
- Third Amended and Restated Supply and License Agreement, dated December 17, 2018, by and among Mayne Pharma, Mayne Pharma International and the Company (Filed With SEC on March 7, 2019)
- Amended and Restated Sublicense Agreement, dated December 17, 2018, by and among Mayne Pharma, Mayne Pharma International and the Company (Filed With SEC on March 7, 2019)
- Employment Letter Agreement, dated December 31, 2018, between the Company and Nicholas J. Virca (Filed With SEC on December 31, 2018)
- Employment Letter Agreement, dated December 31, 2018, between the Company and Garrison J. Hasara (Filed With SEC on December 31, 2018)
- Securities Purchase Agreement, dated January 8, 2018, between the Company and Mayne Pharma (Filed With SEC on January 11, 2018)
- Amendment No. 2 to Second Amended and Restated Supply and License Agreement and Amendment No. 1 to Sublicense Agreement, dated January 10, 2018, by and among Mayne Pharma, Mayne... (Filed With SEC on January 11, 2018)
- Form of Warrant (Filed With SEC on January 11, 2018)
- SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on February 17, 2017)
- AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED SUPPLY AND LICENSE AGREEMENT (Filed With SEC on February 17, 2017)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on February 17, 2017)
- COMMON STOCK PURCHASE WARRANT HEDGEPATH PHARMACEUTICALS, INC. (Filed With SEC on April 15, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 15, 2016)
- COMMON STOCK PURCHASE WARRANT HEDGEPATH PHARMACEUTICALS, INC. (Filed With SEC on February 23, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 23, 2016)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED EQUITY HOLDERS AGREEMENT (Filed With SEC on December 22, 2015)
- Confidential Treatment Requested by HedgePath Pharmaceuticals, Inc., IRS Employer Identification No. 30-0793665 (Filed With SEC on September 9, 2015)
- FOIA CONFIDENTIAL TREATMENT REQUEST BY HEDGEPATH PHARMACEUTICALS, INC. IRS EMPLOYER IDENTIFICATION NUMBER 30-0793665 (Filed With SEC on August 14, 2015)
- SECURITIES PURCHASE AGREEMENT Dated May 15, 2015 by and between HEDGEPATH PHARMACEUTICALS, INC. and MAYNE PHARMAVENTURES PTY LTD TABLE OF CONTENTS (Filed With SEC on August 14, 2015)
- FOIA CONFIDENTIAL TREATMENT REQUEST BY HEDGEPATH PHARMACEUTICALS, INC. IRS EMPLOYER IDENTIFICATION NUMBER 30-0793665 (Filed With SEC on August 14, 2015)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)
- FIRST AMENDMENT TO EXECUTIVE CHAIRMAN AGREEMENT (Filed With SEC on August 14, 2015)
- HEDGEPATH PHARMACEUTICALS, INC. AMENDED AND RESTATED EQUITY HOLDERS AGREEMENT Dated As of May 15, 2015 HEDGEPATH PHARMACEUTICALS, INC. AMENDED AND RESTATED EQUITY HOLDERS AGREEMENT (Filed With SEC on August 14, 2015)
- HEDGEPATH PHARMACEUTICALS, INC. Common Stock Purchase Warrant (Filed With SEC on August 14, 2015)
- FOIA CONFIDENTIAL TREATMENT REQUEST BY HEDGEPATH PHARMACEUTICALS, INC. IRS EMPLOYER IDENTIFICATION NUMBER 30-0793665 Confidential treatment requested with respect to certain... (Filed With SEC on September 9, 2014)
- HEDGEPATH PHARMACEUTICALS, INC. Common Stock Purchase Warrant (Filed With SEC on June 30, 2014)
- EXECUTIVE CHAIRMAN AGREEMENT (Filed With SEC on June 30, 2014)
- HEDGEPATH PHARMACEUTICALS, INC. Common Stock Purchase Warrant (Filed With SEC on June 30, 2014)
- SECURITIES PURCHASE AGREEMENT Dated June 24, 2014 by and between HEDGEPATH PHARMACEUTICALS, INC. and MAYNE PHARMAVENTURES PTY LTD TABLE OF CONTENTS (Filed With SEC on June 30, 2014)
- STOCK PURCHASE AGREEMENT (Filed With SEC on June 30, 2014)
- PROMISSORY NOTE (Filed With SEC on June 30, 2014)
- DEBT FORGIVENESS AGREEMENT (Filed With SEC on June 30, 2014)
- Confidential Treatment Requested by HedgePath Pharmaceuticals, Inc., IRS Employer Identification No. 30-0793665 Confidential treatment requested with respect to certain portions... (Filed With SEC on June 30, 2014)
- Confidential Treatment Requested by HedgePath Pharmaceuticals, Inc., IRS Employer Identification No. 30-0793665 Confidential treatment requested with respect to certain portions... (Filed With SEC on June 30, 2014)
- Confidential Treatment Requested by HedgePath Pharmaceuticals, Inc., IRS Employer Identification No. 30-0793665 Confidential treatment requested with respect to certain portions... (Filed With SEC on June 30, 2014)
- Confidential Treatment Requested by HedgePath Pharmaceuticals, Inc., IRS Employer Identification No. 30-0793665 Confidential treatment requested with respect to certain portions... (Filed With SEC on September 10, 2013)
- AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (Filed With SEC on August 16, 2013)
- CONTRIBUTION AGREEMENT (Filed With SEC on August 16, 2013)
- Case 11-30381-KRH Doc 293 Filed 01/04/13 Entered 01/04/13 13:18:07 Desc Main Document Page 1 of 35 UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF VIRGINIA Richmond Division (Filed With SEC on April 18, 2013)
- Case 11-30381-KRH Doc 291 Filed 01/04/13 Entered 01/04/13 13:12:27 Desc Main Document Page 1 of 31 UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF VIRGINIA Richmond Division (Filed With SEC on April 18, 2013)
- PURCHASE AND SALE AGREEMENT (Filed With SEC on January 5, 2012)
- SHARE EXCHANGE AGREEMENT (Filed With SEC on January 4, 2010)
- SHARE EXCHANGE AGREEMENT By and Among (Filed With SEC on September 4, 2009)
- FIRST MODIFICATION, WAIVER AND ACKNOWLEDGEMENT AGREEMENT (Filed With SEC on September 2, 2009)
- LEASE AGREEMENT (Filed With SEC on July 22, 2009)
- NON-COMPETITION AGREEMENT (Filed With SEC on July 22, 2009)
- ASSET PURCHASE AGREEMENT by and between Bostwick Laboratories, Inc. and (Filed With SEC on July 22, 2009)
- SECOND MODIFICATION, WAIVER AND ACKNOWLEDGEMENT AGREEMENT (Filed With SEC on July 14, 2009)
- ESCROW AGREEMENT (Filed With SEC on June 23, 2009)
- CONVERTIBLE NOTE (Filed With SEC on June 23, 2009)
- SUBSCRIPTION AGREEMENT (Filed With SEC on June 23, 2009)
- MODIFICATION, WAIVER AND ACKNOWLEDGEMENT AGREEMENT (Filed With SEC on September 24, 2008)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 10, 2008)
- SUBSCRIPTION AGREEMENT AND WAIVER TO ANCILLARY AGREEMENT (Filed With SEC on May 9, 2008)
- [Letterhead of Commonwealth Biotechnologies Inc.] March 28, 2008 (Filed With SEC on April 2, 2008)
- ANCILLARY AGREEMENT (Filed With SEC on April 2, 2008)
- COMMONWEALTH BIOTECHNOLOGIES, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 2, 2008)
- VOTING AND LOCK-UP AGREEMENT March 28, 2008 (Filed With SEC on April 2, 2008)
- FORM OF CLASS B WARRANT (Filed With SEC on January 8, 2008)
- FORM OF CLASS A WARRANT (Filed With SEC on January 8, 2008)
- FORM OF SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on January 8, 2008)
- SECURITY AGREEMENT (Filed With SEC on January 8, 2008)
- SUBSCRIPTION AGREEMENT (Filed With SEC on January 8, 2008)
- AMENDED AND RESTATED STOCKPURCHASE AND SALE AGREEMENT by and among Tripos, Inc., a Utah corporation, Tripos UK Holdings Limited, a private limited company incorporated in England,... (Filed With SEC on June 12, 2007)
- STOCK PURCHASE AND SALEAGREEMENT by and among Tripos, Inc., a Utah corporation, Tripos UK Holdings Limited, a private limited company incorporated in England, (Filed With SEC on May 22, 2007)
- TERMS SHEET COMMONWEALTH BIOTECHNOLOGIES INC (Filed With SEC on April 25, 2007)
- TERMS SHEET COMMONWEALTH BIOTECHNOLOGIES INC (Filed With SEC on April 24, 2007)
- COMMONWEALTH BIOTECHNOLOGIES, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 15, 2007)
- VOTING AND LOCK-UP AGREEMENT (Filed With SEC on February 15, 2007)
- PATENT LICENSE AND DEVELOPMENT AGREEMENT (Filed With SEC on January 5, 2006)
- ASSET PURCHASE AGREEMENT (Filed With SEC on December 20, 2004)
- ASSET PURCHASE AGREEMENT (Filed With SEC on November 23, 2004)
- SUBSCRIPTION AGREEMENT (Filed With SEC on June 4, 2004)
- COMMONWEALTH BIOTECHNOLOGIES, INC. FIRST AMENDED ANDRESTATED WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on November 1, 2002)
- COMMONWEALTH BIOTECHNOLOGIES, INC. FIRST AMENDED AND RESTATED WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on November 1, 2002)
